Consolidated Statements of Equity - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance at beginning of period, preferred stock (in shares) at Dec. 31, 2023		800,000
Balance at beginning of period at Dec. 31, 2023	$ 1,798.4	$ 789.9	$ 0.0	$ 1,718.6	$ (349.0)	$ (404.4)	$ 43.3
Balance at beginning of period, common stock (in shares) at Dec. 31, 2023			138,727,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants (RSG) (in shares)			379,188
Shares retired due to RSG vesting (in shares)			(129,011)
Shares retired due to RSG vesting	(1.6)			(1.6)
Shares retired due to common stock repurchase program (in shares)			(1,551,955)
Shares retired due to common stock repurchase program	(13.3)			(27.5)	14.2
Issuance of common stock, net of issuance costs	(0.1)			(0.1)
Share-based compensation	11.2			11.2
Other comprehensive income (loss):
Unrealized foreign currency translation gain (loss), net of tax	(15.0)					(14.9)	(0.1)
Unrealized foreign currency derivative contract gain (loss), net of tax	14.9					14.9
Common stock dividends	(49.6)				(49.6)
Preferred stock dividends	(21.8)				(21.8)
Net income (loss)	(10.6)				(10.4)		(0.2)
Contributions from noncontrolling interests	0.1						0.1
Distributions to noncontrolling interests	(2.2)						(2.2)
Balance at end of period, preferred stock (in shares) at Jun. 30, 2024		800,000
Balance at end of period at Jun. 30, 2024	1,710.4	$ 789.9	$ 0.0	1,700.6	(416.6)	(404.4)	40.9
Balance at end of period, common stock (in shares) at Jun. 30, 2024			137,425,743
Balance at beginning of period, preferred stock (in shares) at Mar. 31, 2024		800,000
Balance at beginning of period at Mar. 31, 2024	1,784.9	$ 789.9	$ 0.0	1,706.5	(347.1)	(406.7)	42.3
Balance at beginning of period, common stock (in shares) at Mar. 31, 2024			138,095,244
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares retired due to common stock repurchase program (in shares)			(669,501)
Shares retired due to common stock repurchase program	(5.8)			(11.9)	6.1
Share-based compensation	6.0			6.0
Other comprehensive income (loss):
Unrealized foreign currency translation gain (loss), net of tax	(2.9)					(2.9)
Unrealized foreign currency derivative contract gain (loss), net of tax	5.2					5.2
Common stock dividends	(16.5)				(16.5)
Preferred stock dividends	(10.9)				(10.9)
Net income (loss)	(48.3)				(48.2)		(0.1)
Contributions from noncontrolling interests	0.1						0.1
Distributions to noncontrolling interests	(1.4)						(1.4)
Balance at end of period, preferred stock (in shares) at Jun. 30, 2024		800,000
Balance at end of period at Jun. 30, 2024	1,710.4	$ 789.9	$ 0.0	1,700.6	(416.6)	(404.4)	40.9
Balance at end of period, common stock (in shares) at Jun. 30, 2024			137,425,743
Balance at beginning of period, preferred stock (in shares) at Dec. 31, 2024		800,000
Balance at beginning of period at Dec. 31, 2024	$ 1,636.0	$ 789.7	$ 0.0	1,712.8	(493.7)	(407.6)	34.8
Balance at beginning of period, common stock (in shares) at Dec. 31, 2024	137,442,778		137,442,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants (RSG) (in shares)			1,562,956
Shares retired due to RSG vesting (in shares)			(712,446)
Shares retired due to RSG vesting	$ (6.7)			(6.7)
Shares retired due to common stock repurchase program (in shares)			(393,493)
Shares retired due to common stock repurchase program	(2.5)			(7.0)	4.5
Share-based compensation	12.8			12.8
Other comprehensive income (loss):
Unrealized foreign currency translation gain (loss), net of tax	89.5					87.7	1.8
Unrealized foreign currency derivative contract gain (loss), net of tax	(49.2)					(49.2)
Common stock dividends	(33.1)				(33.1)
Preferred stock dividends	(21.8)				(21.8)
Net income (loss)	(24.0)				(25.4)		1.4
Distributions to noncontrolling interests	(4.7)						(4.7)
Balance at end of period, preferred stock (in shares) at Jun. 30, 2025		800,000
Balance at end of period at Jun. 30, 2025	$ 1,596.3	$ 789.7	$ 0.0	1,711.9	(569.5)	(369.1)	33.3
Balance at end of period, common stock (in shares) at Jun. 30, 2025	137,899,795		137,899,795
Balance at beginning of period, preferred stock (in shares) at Mar. 31, 2025		800,000
Balance at beginning of period at Mar. 31, 2025	$ 1,592.2	$ 789.7	$ 0.0	1,712.4	(551.1)	(393.0)	34.2
Balance at beginning of period, common stock (in shares) at Mar. 31, 2025			138,293,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares retired due to common stock repurchase program (in shares)			(393,493)
Shares retired due to common stock repurchase program	(2.5)			(7.0)	4.5
Share-based compensation	6.5			6.5
Other comprehensive income (loss):
Unrealized foreign currency translation gain (loss), net of tax	62.9					61.2	1.7
Unrealized foreign currency derivative contract gain (loss), net of tax	(37.3)					(37.3)
Common stock dividends	(16.5)				(16.5)
Preferred stock dividends	(10.9)				(10.9)
Net income (loss)	5.6				4.5		1.1
Distributions to noncontrolling interests	(3.7)						(3.7)
Balance at end of period, preferred stock (in shares) at Jun. 30, 2025		800,000
Balance at end of period at Jun. 30, 2025	$ 1,596.3	$ 789.7	$ 0.0	$ 1,711.9	$ (569.5)	$ (369.1)	$ 33.3
Balance at end of period, common stock (in shares) at Jun. 30, 2025	137,899,795		137,899,795